Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 92 articles:
HTML format
Text format



Single Articles


    July 2017
  1. CHANDRASEKHARAPPA SC, Chinn SB, Donovan FX, Chowdhury NI, et al
    Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30802.
    PubMed     Text format     Abstract available


    June 2017
  2. LEE AWM, Tung SY, Ng WT, Lee V, et al
    A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30850.
    PubMed     Text format     Abstract available


  3. DAVID JM, Ho AS, Luu M, Yoshida EJ, et al
    Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30843.
    PubMed     Text format     Abstract available


  4. WANG FH, Wang Y, Sun GP, Chen JH, et al
    Efficacy and safety of recombinant human lymphotoxin-alpha derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30845.
    PubMed     Text format     Abstract available


  5. LIN WC, Ding YF, Hsu HL, Chang JH, et al
    Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Cancer. 2017 Jun 13. doi: 10.1002/cncr.30823.
    PubMed     Text format     Abstract available


  6. ALI SM, Yao M, Yao J, Wang J, et al
    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30781.
    PubMed     Text format     Abstract available


    May 2017
  7. CATENACCI DV, Ang A, Liao WL, Shen J, et al
    MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Cancer. 2017;123:1061-1070.
    PubMed     Text format     Abstract available


  8. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Text format     Abstract available


  9. PAI SI, Faquin WC
    Programmed cell death ligand 1 as a biomarker in head and neck cancer.
    Cancer. 2017 May 4. doi: 10.1002/cncy.21872.
    PubMed     Text format    


  10. NAIK KB, Liu Y, Goodman M, Gillespie TW, et al
    Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30763.
    PubMed     Text format     Abstract available


    April 2017
  11. ZUMSTEG ZS, Lok BH, Ho AS, Drill E, et al
    The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Cancer. 2017;123:1345-1353.
    PubMed     Text format     Abstract available


  12. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Text format     Abstract available


  13. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


    March 2017
  14. HAJEK M, Sewell A, Kaech S, Burtness B, et al
    TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30570.
    PubMed     Text format     Abstract available


  15. CHEN T, Zhang J, Chen Z, Van Waes C, et al
    Genetic alterations in TRAF3 and CYLD that regulate nuclear factor kappaB and interferon signaling define head and neck cancer subsets harboring human papillomavirus.
    Cancer. 2017 Mar 13. doi: 10.1002/cncr.30659.
    PubMed     Text format    


  16. BRANDLER TC, Zhou F, Liu CZ, Cho M, et al
    Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Cancer. 2017 Mar 10. doi: 10.1002/cncy.21848.
    PubMed     Text format     Abstract available


    February 2017
  17. LIU Z, Chang ET, Liu Q, Cai Y, et al
    Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30643.
    PubMed     Text format     Abstract available


  18. GRABOYES EM, Garrett-Mayer E, Sharma AK, Lentsch EJ, et al
    Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30651.
    PubMed     Text format     Abstract available


  19. ZEVALLOS JP, Mazul AL
    The complex relation between race, sex, and human papillomavirus status in head and neck cancer.
    Cancer. 2017 Feb 27. doi: 10.1002/cncr.30619.
    PubMed     Text format    


  20. HUANG J, Fogg M, Wirth LJ, Daley H, et al
    Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
    Cancer. 2017 Feb 21. doi: 10.1002/cncr.30541.
    PubMed     Text format     Abstract available



  21. Immunotherapy drug improves survival for patients with head and neck cancer.
    Cancer. 2017;123:545.
    PubMed     Text format    


  22. DRAHOS J, Ricker W, Pfeiffer RM, Cook MB, et al
    Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
    Cancer. 2017;123:657-665.
    PubMed     Text format     Abstract available


  23. TABERNA M, Inglehart RC, Pickard RK, Fakhry C, et al
    Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.
    Cancer. 2017 Feb 14. doi: 10.1002/cncr.30564.
    PubMed     Text format     Abstract available


  24. ZHAO L, Dias-Santagata D, Sadow PM, Faquin WC, et al
    Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21839.
    PubMed     Text format     Abstract available


  25. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Text format     Abstract available


  26. GRABOYES EM, Zhan KY, Garrett-Mayer E, Lentsch EJ, et al
    Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2017 Feb 9. doi: 10.1002/cncr.30586.
    PubMed     Text format     Abstract available


  27. MANYAM BV, Garsa AA, Chin RI, Reddy CA, et al
    A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Cancer. 2017 Feb 7. doi: 10.1002/cncr.30601.
    PubMed     Text format     Abstract available


  28. YEN YC, Chang JH, Lin WC, Chiou JF, et al
    Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
    Cancer. 2017 Feb 2. doi: 10.1002/cncr.30565.
    PubMed     Text format     Abstract available


  29. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Text format     Abstract available


    January 2017
  30. WONG TH, Skanthakumar T, Nadkarni N, Nguyen HV, et al
    Survival of patients with head and neck squamous cell carcinoma by housing subsidy in a tiered public housing system.
    Cancer. 2017 Jan 30. doi: 10.1002/cncr.30557.
    PubMed     Text format     Abstract available


  31. JABBOUR J, Milross C, Sundaresan P, Ebrahimi A, et al
    Education and support needs in patients with head and neck cancer: A multi-institutional survey.
    Cancer. 2017 Jan 12. doi: 10.1002/cncr.30535.
    PubMed     Text format     Abstract available


  32. CHUANG SL, Su WW, Chen SL, Yen AM, et al
    Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers.
    Cancer. 2017 Jan 5. doi: 10.1002/cncr.30517.
    PubMed     Text format     Abstract available


  33. HUTCHESON KA, Barrow MP, Barringer DA, Knott JK, et al
    Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.
    Cancer. 2017;123:62-70.
    PubMed     Text format     Abstract available


  34. SHER DJ, Rusthoven CG, Khan SA, Fidler MJ, et al
    National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:273-282.
    PubMed     Text format     Abstract available


    December 2016
  35. PEZZI TA, Mohamed AS, Sheu T, Blanchard P, et al
    Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30493.
    PubMed     Text format     Abstract available


  36. ZUMSTEG ZS, Kim S, David JM, Yoshida EJ, et al
    Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30508.
    PubMed     Text format     Abstract available


  37. PENG H, Chen L, Li WF, Guo R, et al
    Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30520.
    PubMed     Text format     Abstract available


  38. RAMAKODI MP, Devarajan K, Blackman E, Gibbs D, et al
    Integrative genomic analysis identifies ancestry-related expression quantitative trait loci on DNA polymerase beta and supports the association of genetic ancestry with survival disparities in head and neck squamous cell carcinoma.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30457.
    PubMed     Text format     Abstract available


  39. BAUMAN JE, Cohen E, Ferris RL, Adelstein DJ, et al
    Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30449.
    PubMed     Text format     Abstract available


  40. BISHOP JA, French CA, Ali SZ
    Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Cancer. 2016;124:901-908.
    PubMed     Text format     Abstract available


    November 2016
  41. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Text format     Abstract available


  42. SOMNAY YR, Yu XM, Lloyd RV, Leverson G, et al
    Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
    Cancer. 2016 Nov 2. doi: 10.1002/cncr.30403.
    PubMed     Text format     Abstract available


    October 2016
  43. TAJUDEEN BA, Taylor ZD, Garritano J, Cheng H, et al
    Dynamic optical contrast imaging as a novel modality for rapidly distinguishing head and neck squamous cell carcinoma from surrounding normal tissue.
    Cancer. 2016 Oct 20. doi: 10.1002/cncr.30338.
    PubMed     Text format     Abstract available


  44. HAUGEN BR
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
    Cancer. 2016 Oct 14. doi: 10.1002/cncr.30360.
    PubMed     Text format     Abstract available


  45. STOKES WA, Jones BL, Bhatia S, Oweida AJ, et al
    A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
    Cancer. 2016 Oct 11. doi: 10.1002/cncr.30382.
    PubMed     Text format     Abstract available


    September 2016
  46. TAYLOR LJ, Greenberg CC, Lidor AO, Leverson GE, et al
    Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Sep 28. doi: 10.1002/cncr.30368.
    PubMed     Text format     Abstract available


  47. BIZZARRO T, Martini M, Capodimonti S, Straccia P, et al
    Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21777.
    PubMed     Text format     Abstract available


  48. BEADLE BM, Liao KP, Giordano SH, Garden AS, et al
    Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Cancer. 2016 Sep 23. doi: 10.1002/cncr.30350.
    PubMed     Text format     Abstract available


  49. CHAU NG, Haddad RI
    Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30352.
    PubMed     Text format    


  50. JIMENO A, Posner MR, Wirth LJ, Saba NF, et al
    A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Sep 20. doi: 10.1002/cncr.30317.
    PubMed     Text format     Abstract available


    August 2016
  51. MAZUL AL, Taylor JM, Divaris K, Weissler MC, et al
    Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Cancer. 2016 Aug 29. doi: 10.1002/cncr.30312.
    PubMed     Text format     Abstract available


  52. JIMENO A, Machiels JP, Wirth L, Specenier P, et al
    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30256.
    PubMed     Text format     Abstract available


  53. SHERMAN SI, Clary DO, Elisei R, Schlumberger MJ, et al
    Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30252.
    PubMed     Text format     Abstract available


  54. LUBITZ CC, Sosa JA
    The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
    Cancer. 2016 Aug 12. doi: 10.1002/cncr.30201.
    PubMed     Text format     Abstract available


  55. WARD MC, Reddy CA, Adelstein DJ, Koyfman SA, et al
    Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.
    Cancer. 2016 Aug 9. doi: 10.1002/cncr.30214.
    PubMed     Text format     Abstract available


  56. NAGHAVI AO, Echevarria MI, Grass GD, Strom TJ, et al
    Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30212.
    PubMed     Text format     Abstract available


    July 2016
  57. DIVI V, Harris J, Harari PM, Cooper JS, et al
    Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30204.
    PubMed     Text format     Abstract available


  58. KU GY, Kriplani A, Janjigian YY, Kelsen DP, et al
    Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
    Cancer. 2016;122:2083-90.
    PubMed     Text format     Abstract available


  59. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Text format     Abstract available


    June 2016
  60. YIN LX, Ha PK
    Genetic alterations in salivary gland cancers.
    Cancer. 2016;122:1822-31.
    PubMed     Text format     Abstract available


  61. GARDEN AS, Fuller CD, Rosenthal DI, William WN Jr, et al
    Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2016;122:1702-7.
    PubMed     Text format     Abstract available


  62. WEISS J, Grilley Olson J, Deal AM, Chera B, et al
    Using the galactose-alpha-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.
    Cancer. 2016;122:1697-701.
    PubMed     Text format     Abstract available


    May 2016
  63. LIN CC, Fedewa SA, Prickett KK, Higgins KA, et al
    Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer.
    Cancer. 2016 May 31. doi: 10.1002/cncr.30122.
    PubMed     Text format     Abstract available


  64. WEISS JM, Bagley S, Hwang WT, Bauml J, et al
    Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma.
    Cancer. 2016 May 19. doi: 10.1002/cncr.30067.
    PubMed     Text format     Abstract available


  65. RETTIG EM, D'Souza G, Thompson CB, Koch WM, et al
    Health-related quality of life before and after head and neck squamous cell carcinoma: Analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    Cancer. 2016 May 16. doi: 10.1002/cncr.30005.
    PubMed     Text format     Abstract available


  66. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available


  67. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available


  68. BELL D, Bell AH, Bondaruk J, Hanna EY, et al
    In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
    Cancer. 2016;122:1513-22.
    PubMed     Text format     Abstract available


  69. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available


  70. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    March 2016
  71. KUO P, Sosa JA, Burtness BA, Husain ZA, et al
    Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Cancer. 2016 Mar 28. doi: 10.1002/cncr.29962.
    PubMed     Text format     Abstract available


  72. AMINI A, Jones BL, McDermott JD, Serracino HS, et al
    Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29956.
    PubMed     Text format     Abstract available


  73. ROBERTS TJ, Colevas AD, Hara W, Holsinger FC, et al
    Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29932.
    PubMed     Text format     Abstract available


  74. SONG YS, Lim JA, Choi H, Won JK, et al
    Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29934.
    PubMed     Text format     Abstract available


  75. PRINTZ C
    Developments in precision medicine: Studies highlight new applications for cancer chemoprevention, treatment.
    Cancer. 2016;122:661-2.
    PubMed     Text format    


  76. ARMENIAN SH, Bhatia S
    Looking back to inform the future: Lesson learned from survivors of childhood cancer.
    Cancer. 2016;122:678-80.
    PubMed     Text format    


  77. FRIEDMAN DN, Chou JF, Oeffinger KC, Kleinerman RA, et al
    Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
    Cancer. 2016;122:773-81.
    PubMed     Text format     Abstract available


  78. MOR V, Joyce NR, Cote DL, Gidwani RA, et al
    The rise of concurrent care for veterans with advanced cancer at the end of life.
    Cancer. 2016;122:782-90.
    PubMed     Text format     Abstract available


    February 2016
  79. MCDOWELL LJ, Young RJ, Johnston ML, Tan TJ, et al
    p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    Cancer. 2016 Feb 16. doi: 10.1002/cncr.29901.
    PubMed     Text format     Abstract available


  80. PAN JJ, Ng WT, Zong JF, Chan LL, et al
    Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Cancer. 2016;122:546-58.
    PubMed     Text format     Abstract available


  81. FRAKES JM, Naghavi AO, Demetriou SK, Strom TJ, et al
    Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Cancer. 2016;122:634-41.
    PubMed     Text format     Abstract available


  82. CAPOZZI LC, McNeely ML, Lau HY, Reimer RA, et al
    Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial.
    Cancer. 2016 Feb 1. doi: 10.1002/cncr.29863.
    PubMed     Text format     Abstract available


    January 2016
  83. PRASAD ML, Vyas M, Horne MJ, Virk RK, et al
    NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Cancer. 2016 Jan 19. doi: 10.1002/cncr.29887.
    PubMed     Text format     Abstract available


    December 2015
  84. LIN SH, Zhang N, Godby J, Wang J, et al
    Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
    Cancer. 2015 Dec 30. doi: 10.1002/cncr.29857.
    PubMed     Text format     Abstract available


  85. VERDONCK-DE LEEUW IM, Cuijpers P, Leemans CR
    Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29850.
    PubMed     Text format    


  86. ROH JL, Kim SA
    Reply to pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Cancer. 2015 Dec 22. doi: 10.1002/cncr.29849.
    PubMed     Text format    


    October 2015
  87. WANG W, Su X, He K, Wang Y, et al
    Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29689.
    PubMed     Text format     Abstract available


  88. QIAN G, Jiang N, Wang D, Newman S, et al
    Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer. 2015;121:3600-11.
    PubMed     Text format     Abstract available


  89. LAGERGREN J, Andersson G, Talback M, Drefahl S, et al
    Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
    Cancer. 2015 Oct 8. doi: 10.1002/cncr.29731.
    PubMed     Text format     Abstract available


  90. DAHLSTROM KR, Li G, Hussey CS, Vo JT, et al
    Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Cancer. 2015;121:3455-64.
    PubMed     Text format     Abstract available


    August 2015
  91. WANG LY, Roman BR, Migliacci JC, Palmer FL, et al
    Cost-effectiveness analysis of papillary thyroid cancer surveillance.
    Cancer. 2015 Aug 17. doi: 10.1002/cncr.29633.
    PubMed     Text format     Abstract available


    July 2015
  92. SAWKA AM, Straus S, Rodin G, Heus L, et al
    Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.
    Cancer. 2015 Jul 20. doi: 10.1002/cncr.29548.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: